Salute e Benessere | Diffusione Gratuita di Comunicati Stampa in inglese| Pubblica i tuoi comunicati con informazione.news

Ultimovacs Announces Publication of Phase II FOCUS Trial Results on medRxiv

Oslo, October 25, 2024:Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology company developing immunotherapeutic cancer vaccines, today announced that the results from Phase II FOCUS trial (NCT05075122) have been published online on the preprint platform medRxiv. As previously reported , topline data readout demonstrated that adding UV1 to the standard of care pembrolizumab did not lead to clinical benefits in progression free survival or overall...

Neuromorphic Computing Market worth $1,325.2 million by 2030 - Exclusive Report…

Browse in-depth TOC on "Neuromorphic Computing Market" 167 – Tables69 – Figures256 – Pages Browse in-depth TOC on "Neuromorphic Computing Market" 167 – Tables 69 – Figures 256 – Pages Neuromorphic Computing Market Report Scope: By Offering, software segment is projected to grow at a high CAGR of neuromorphic computing market during the forecast period. The software segment is expected to grow at a fast rate in the forecasted period. Neuromorphic software has its roots in...

Bridge to Life and ULS Coimbra Announce Collaboration to Enhance Preservation of…

The initiative kicks off with the development and launch of a case study demonstrating the important organ transplantation research and procedures being conducted at ULS Coimbra. The initiative kicks off with the development and launch of a case study demonstrating the important organ transplantation research and procedures being conducted at ULS Coimbra. "Bridge to Life is excited to support the innovations and advancements in organ transplantation at ULS Coimbra and look forward to...

Press Release: Sanofi Q3: 15.7% sales growth boosted by earlier-than-anticipated…

Sanofi Q3: 15.7% sales growth boosted by earlier-than-anticipated vaccine sales; 2024 business EPS guidance raised due to strong business performanceParis, October 25, 2024Q3 sales growth of 15.7% at CER and business EPS (1)of €2.86Dupixent sales up 23.8% to €3,476 million; full-year 2024 target of ~€13 billion confirmedPharma launches up 67.1% to €727 million, led by ALTUVIIIO, Nexviazyme and RezurockVaccines sales up 25.5%, boosted by phasing of flu sales, and by...

Independent meta-analyses by Melanoma Institute of Australia on CP-GEP model in…

The MIA-led study analyzed data from independent external validation studies on the Merlin CP-GEP model published between 2020 and 2024. These studies spanned patient records from 4 countries, offering a comprehensive view of the model's predictive accuracy. The analysis revealed that the CP-GEP model achieved a sensitivity of 93%, meaning it accurately identified 93% of patients with nodal metastasis, while achieving an NPV (Negative Predictive Value) of 95%, indicating that 95% of patients…

Global Protein Chip Market to Surge at a CAGR of ~7% by 2030 | DelveInsight

Key Takeaways from the Protein Chip Market Report Key Takeaways from the Protein Chip Market Report To read more about the latest highlights related to the protein chip market, get a snapshot of the key highlights entailed in the Global Protein Chip Market Report Protein Chip Overview A protein chip, also known as a protein microarray, is a high-throughput platform used to study protein interactions, function, and expression on a large scale. It consists of thousands of...

IVD Assay Development Market to be Worth $8.39 Billion by 2031--Exclusive Report…

The IVD assay development market is projected to reach $8.39 billion by 2031, at a CAGR of 7.9% from 2024 to 2031. The IVD assay development market is projected to reach$8.39 billionby 2031, at a CAGR of 7.9% from 2024 to 2031. Download FREE PDF Brochure Of IVD Assay Development Market - https://www.meticulousresearch.com/download-sample-report/cp_id=6037 In vitro diagnostics (IVD) assay development services provide comprehensive, end-to-end contracting solutions. These services...

Pediatric Orphan Drug Market Size to Grow USD 102180 Million by 2030 at a CAGR…

Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-26J17580/Global_Pediatric_Orphan_Drug_Market_Research_Report_2024 Get Free Sample :https://reports.valuates.com/request/sample/QYRE-Auto-26J17580/Global_Pediatric_Orphan_Drug_Market_Research_Report_2024 Major Factors Driving the Growth of Pediatric Orphan Drug Market: The Pediatric Orphan Drug Market is poised for significant growth in the coming years as the demand for specialized treatments for rare pediatric...

Inside information: Orion terminates ODM-111 development program due to narrow…

ORION CORPORATIONSTOCK EXCHANGE RELEASE – INSIDE INFORMATION 24 OCTOBER 2024 at 19.50 EEST Inside information: Orion terminates ODM-111 development program due to narrow therapeutic window of the molecule Orion Corporation has decided to terminate the ODM-111 development program based on the risk-benefit analysis on the results of a longer non-clinical toxicology study. Recent findings indicate that the profile of the ODM-111 molecule does not support long-term use of ODM-111...

GUERBET : Revenue at September 30, 2024.

Revenue at September 30, 2024Continued growth momentum 9-month revenue: €620.5m, up 9.6% at CER 1 In the third quarter, momentum remained strong (+5.4% at CER), driven by the Americas (+13.1%) and Asia (+8.1%), while performance in EMEA (-2.3%) was once again impacted by the continued implementation of the new supply chain in France2024 annual targets confirmedRevenue: expected growth of over 9% on a like-for-like basis and at CERProfitability:...

ONWARD® Medical Publishes Prospectus for Listing of New Shares

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)EINDHOVEN, the Netherlands, Oct.24, 2024(GLOBE NEWSWIRE) --ONWARD Medical N.V. (Euronext: ONWD) (the “Company” or “ONWARD Medical”), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), announces today that it has published a...

Organoids Market Size To Reach $15.01 Billion By 2031 | CAGR 22.3%: The Insight…

Browse Detailed Analysis: https://www.theinsightpartners.com/reports/organoids-market Browse Detailed Analysis:https://www.theinsightpartners.com/reports/organoids-market Overview of Report Findings Market Growth : The organoid market is expected to reach U.S. $ 15.01 billionby 2031 from U.S. $ 3.03 billionin 2023, registering a CAGR of 22.1% during the forecast period. Organoids are microscopic and self-organized 3D structures produced in vitro from stem cells. They...

Radiopharmaceuticals Market Size To Reach $26.51 Billion By 2031 | CAGR 14.4%…

The radiopharmaceuticals market encompasses a growing number of clinical trials in targeted therapy that are expected to gain prominence in the coming years. The radiopharmaceuticals market encompasses a growing number of clinical trials in targeted therapy that are expected to gain prominence in the coming years. Global radiopharmaceuticals market is recording significant growth owing to the surging incidences of chronic diseases such as lung diseases, cancer, stroke, Alzheimer's,...

Biologics Market Size To Reach $1,793.9 Billion By 2031 | CAGR 18.2%: The…

The global biologics market observing significant growth owing to the increasing occurrence of chronic diseases globally and surging preference for outsourcing biologics manufacturing operations. The biologics market entails an array of platforms and services that are expected to dominate the market in the coming years. The report carries out an in-depth analysis of market trends, key players, and future opportunities. The global biologics market observing significant growth owing to the...

Pharmaceutical Drying Equipment Market to Hit USD 8.18 Billion by 2029 with 7.1%…

Browse in-depth TOC on "Pharmaceutical Drying Equipment Market" Browse in-depth TOC on "Pharmaceutical Drying Equipment Market" 221 - Tables 52 - Figures 226 - Pages Based on type, the pharmaceutical drying equipment market is segmented into vacuum dryers, spray dryers, freeze dryers, fluidized bed dryers, and other dryers. Among these, in 2023, freeze dryer segment the fastest growing segment in the pharmaceutical drying equipment market. This is due to the increasing...

Mölnlycke® Health Care and Transdiagen announce research collaboration to drive…

James Harding, CEO, Transdiagen added "We are thrilled to be working with Mölnlycke on this R&D programme. This collaboration will allow Mölnlycke access to TDG's novel models to generate functional insights regarding the mode of action of innovative and biological wound treatment solutions. We believe this marks a new chapter in the approach to data driven, evidence-based product development for the treatment of complex wounds." James Harding, CEO, Transdiagen added "We are…

Ultimovacs Announces Publication of Phase II FOCUS Trial Results on medRxiv

Neuromorphic Computing Market worth $1,325.2 million by 2030 - Exclusive Report…

Orexo initiates new study of OX640 in participants with allergic rhinitis

Alvotech Meeting Investors and Presenting at the Jefferies 2024 London…

Endo Announces Peyronie's Disease Presentation at the SurgeWest Annual Meeting…

Invitation: Sobi's Aspaveli® and the Phase 3 VALIANT data in Nephrology call

Zymeworks Presents New Preclinical Data on Antibody-Drug Conjugate Programs at…

Microencapsulation Market worth $24.07 billion by 2029 - Exclusive Report by…

Clock Change Chaos: 40% of Shift Workers Struggle with Sleep as Clocks Go Back

Meret Gaugler, PhD, joins Page Therapeutics as independent member of the Board…

Bridge to Life and ULS Coimbra Announce Collaboration to Enhance Preservation of…

Press Release: Sanofi Q3: 15.7% sales growth boosted by earlier-than-anticipated…

Independent meta-analyses by Melanoma Institute of Australia on CP-GEP model in…

Global Protein Chip Market to Surge at a CAGR of ~7% by 2030 | DelveInsight

IVD Assay Development Market to be Worth $8.39 Billion by 2031--Exclusive Report…

Pediatric Orphan Drug Market Size to Grow USD 102180 Million by 2030 at a CAGR…

Inside information: Orion terminates ODM-111 development program due to narrow…

GUERBET : Revenue at September 30, 2024.

ONWARD® Medical Publishes Prospectus for Listing of New Shares

Organoids Market Size To Reach $15.01 Billion By 2031 | CAGR 22.3%: The Insight…

Radiopharmaceuticals Market Size To Reach $26.51 Billion By 2031 | CAGR 14.4%…

Biologics Market Size To Reach $1,793.9 Billion By 2031 | CAGR 18.2%: The…

Pharmaceutical Drying Equipment Market to Hit USD 8.18 Billion by 2029 with 7.1%…

Mölnlycke® Health Care and Transdiagen announce research collaboration to drive…